Types of Diets And Supplements For Obesity
DOI:
https://doi.org/10.5281/zenodo.10444857Keywords:
Obesity, Diet, Dietary SupplementsAbstract
Obesity is a pandemic disease that poses a serious problem for the entire world population. Preventive and non-pharmacological treatments for obesity include changing dietary habits and increasing physical activity. However, correction of dietary habits alone may be insufficient in the treatment of obesity. Therefore, the use of some dietary supplements in obesity may bring beneficial results. Dietary supplements in obesity management contain numerous components with thermogenic, lipotropic, satiety and other metabolic effects. However, these supplements are not medicines. Therefore, they are not prescribed to treat or cure obesity. There are many options for dietary supplements for the treatment of obesity. Some of the most popular supplements claim to improve nutrition, increase energy, build muscle or burn fat. These supplements with beneficial effects that support the reduction of excess body weight are taken as health aids. These supplements are usually taken orally and contain vitamins, minerals, fibre, caffeine and different herbs/ingredients.
References
Rodríguezhernández H., Simentalmendía L.E., Rodríguezramírez G., Reyesromero M.A. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Internet J. Endocrinol. 2013:678159.
Vettori A, Paolacci S, Maltese PE, Herbst KL, Cestari M, Michelini S, et al. Genetic determinants of the effects of training on muscle and adipose tissue homeostasis in obesity associated with lymphedema. Lymphat Res Biol. 2021;19:322-33.
Vettori A, Pompucci G, Paolini B, del Ciondolo I, Bressan S, Dundar M, et al. Geneob Project genetic background, nutrition and obesity: a review. Eur Rev Med Pharmacol Sci. 2019;23:1751-61.
Li Z., Ji G. Ginseng and obesity. J. Gins. Res. 2018; 42: 1–8.
Null R.O.I.C., Consultation W. Obesity: Preventing and Managing the Global Epidemic. World Health Organization. 2000;15 (1): 18–30.
Van Gaal L.F., Mertens I.L., De Block C.E., Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444 (7121): 875–880.
Robertson M.D., Wright J.W., Loizon E., Robertson M.D., Wright J.W., Loizon, E. Insulin-sensitizing effects on muscle and adipose tissue after dietary fiber intake in men and women with metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism. 2012;97 (9): 3326–3332.
World Health Organization. Obesity and Overweight. Available online [EB/OL]. [2016- 11-12]. http://www.who.int/mediacentre/factsheets/fs311/en.
World Health Organization Regional Office for Europe. Available online [EB/OL]. [2016- 11- 12]. http://www.euro.who.int/data/assets/pdf_file/0003/294474 /European Food- Nutrition- Action-Plan- 20152020-en.
Andolfi C., Fisichella P.M. Epidemiology of Obesity and Associated Comorbidities. J. Laparoendosc. Adv. Surg. Tech. 2018;28: 919–924.
Ariana M. Chao, Kerry M. Quigley, and Thomas A. Wadden. Dietary interventions for obesity: clinical and mechanistic findings. J Clin Invest. 2021;131(1):e140065.
Williamson DA., Anton SD., Han H., Champagne CM., Allen R., Leblanc E., et al. Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST study. J Behav Med. 2010;33(4):305–314.
Acharya SD., Elci OU., Sereika SM., Music E., Styn MA., Turk MW., et al. Adherence to a behavioral weight loss treatment program enhances weight loss and improvements in biomarkers. Patient Prefer Adherence. 2009;3:151–160.
Wadden TA., Neiberg RH., Wing RR., Clark JM., Delahanty LM., Hill JO., et al. Four-year weight losses in the Look AHEAD study: factors associatedwith long-term success. Obesity (Silver Spring). 2011;19(10):1987–1998.
Wadden TA., Webb VL., Moran CH., Bailer BA. Lifestyle modification for obesity: new developments in diet, physical activity, and behavior therapy. Circulation. 2012;125(9):1157–1170.
Hall KD., Guo J. Obesity energetics: body weight regulation and the effects of diet composition. Gastroenterology. 2017;152(7):1718–1727.e3
Del Corral P., Chandler-Laney PC., Casazza K., Gower BA., Hunter GR. Effect of dietary adherence with or without exercise on weight loss: a mechanistic approach to a global problem. J Clin Endocrinol Metab. 2009;94(5):1602–1607.
Jensen MD., Ryan DH., Apovian CM., Ard JD., Comuzzie AG., Donato KA., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and The Obesity Society. Obesity. 2014;22(S2):S41–S410.
European Commission. Nutrition. EU website. https://ec.europa.eu/jrc/en/health-knowledge- gateway/promotion-prevention/nutrition. Updated 1/31/20. Accessed October 2, 2020.
Bonettı G., Herbst Karen L., Donato Kevın., Dhulı K., Kıanı Ak., Aquılantı B, et al. Dietary supplements for obesity. J Prev Med Hyg. 2022; 63: e160-168.
Jensen MD., Ryan DH., Apovian CM., Ard JD., Comuzzie AG., Donato KA., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and The Obesity Society. Obesity. 2014;22(S2):S41–S410.
Heymsfield SB., van Mierlo CA., van der Knaap HC., Heo M., Frier HI. Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord. 2003;27(5):537–549.
Ryan DH., Espeland MA., Foster GD., Haffner SM., Hubbard VS., Johnson KC., et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610–628.
Dhuli K., Ceccarini MR., Precone V., Maltese PE., Bonetti G., Paolacci S., et al. Improvement of quality of life by intake of hydroxytyrosol in patients with lymphedema and association of lymphedema genes with obesity. Eur Rev Med Pharmacol Sci. 2021;25:33-42.
Batsis JA., Apolzan JW., Bagley PJ., Blunt HB., Divan V., Gill S., et al. Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss. Obesity. 2021;29:1102- 13.
Ríos-Hoyo A., Gutiérrez-Salmeán G. New dietary supplements for obesity: what we currently know. Curr Obes Rep. 2016;5:262- 70.
Blanck HM., Serdula MK., Gillespie C., Galuska DA., Sharpe PA., Conway JM., et al. Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc. 2007;107:441-7.
A race of results. Nutr Bus. J 2016;21:1, 3-7.
Bailey RL., Gahche JJ., Miller PE., Thomas PR., Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173:355-61.
Walter S., Kunst A., Mackenbach J., Hofman A., Tiemeier H. Mortality and disability: the effect of overweight and obesity. Int J Obes. 2009;33:1410-8.
Dwyer JT., Allison DB., Coates PM. Dietary supplements in weight reduction. J Am Diet Assoc 2005;105:S80-6.
Natural Medicines Comprehensive Database. Guar Gum. 2011.
U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. 2019.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 MEHES JOURNAL
This work is licensed under a Creative Commons Attribution 4.0 International License.